| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/04/2012 | CN202096912U Antigen emulsifying device for immunity |
| 01/04/2012 | CN1944460B Alr polypeptide and application thereof |
| 01/04/2012 | CN102307995A Transformed soybean plant which stores vaccine, and use thereof |
| 01/04/2012 | CN102307989A Method for producing dendritic cells |
| 01/04/2012 | CN102307901A Binding members against IL-1R1 |
| 01/04/2012 | CN102307900A Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| 01/04/2012 | CN102307899A Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune and cardiovascular disorders |
| 01/04/2012 | CN102307898A Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent |
| 01/04/2012 | CN102307893A Peptides for vaccine |
| 01/04/2012 | CN102307891A WDRPUH epitope peptides and vaccines containing the same |
| 01/04/2012 | CN102307595A Antibodies and methods for treating estrogen receptor-associated diseases |
| 01/04/2012 | CN102307594A Treatment of mucositis with kallikrein inhibitors |
| 01/04/2012 | CN102307593A Modulation of axon degeneration |
| 01/04/2012 | CN102307592A Novel gp41 Antigens |
| 01/04/2012 | CN102307591A Modified RSV F proteins and methods of their use |
| 01/04/2012 | CN102307590A Influenza vaccines with reduced amounts of squalene |
| 01/04/2012 | CN102304529A Preparation method of rabbit hemorrhagic fever virus empty capsid antigen |
| 01/04/2012 | CN102304527A Enterococcus antigens |
| 01/04/2012 | CN102304496A Attenuated culture of high-pathogenic porcine reproductive and respiratory syndrome virus attenuated vaccine GDr strain |
| 01/04/2012 | CN102304495A Recombinant influenza virus capable of expressing HA (hemagglutinin) protein with high efficiency and preparation method and application thereof |
| 01/04/2012 | CN102304494A Duck hemorrhagic ovaritis virus strain, inactivated vaccine and preparation method thereof |
| 01/04/2012 | CN102304185A Fusion protein surface immunogenic protein-target of RNA III activating protein (SIP-TRAP) for preventing bovine mastitis and preparation method and use thereof |
| 01/04/2012 | CN102304184A Neuropilin antagonists |
| 01/04/2012 | CN102304174A Milk cow Streptococcus uberis subunit vaccine GapC protein, and preparation method and application thereof |
| 01/04/2012 | CN102302778A Preparation method and application of traditional Chinese medicinal immunoglobulin compound preparation |
| 01/04/2012 | CN102302777A Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases |
| 01/04/2012 | CN102302776A Injectable vaccines against multiple meningococcal serogroups |
| 01/04/2012 | CN102302775A Combined inactivated vaccine of Newcastle disease and H9 subtype avian influenza and preparation method thereof |
| 01/04/2012 | CN102302774A Peste des petits ruminants recombinant goat pox virus live vector vaccines |
| 01/04/2012 | CN102302773A Refrigerator-temperature stable influenza vaccine compositions |
| 01/04/2012 | CN102302772A Duck hemorrhagic ovaritis (DHO) inactivated vaccine and preparation method thereof |
| 01/04/2012 | CN102302771A Polyvalent inactivity vaccine for preventing and treating atrophic rhinitis of swine |
| 01/04/2012 | CN101850113B Vaccine for preventing porcine reproductive and respiratory syndrome |
| 01/04/2012 | CN101791405B Method for preparing yolk immunoglobulin vaccine for resisting porphyromonas gingivalis |
| 01/04/2012 | CN101717775B Single-chain antibody gene of anti-human death receptor 5 |
| 01/04/2012 | CN101638624B Hyphal development related gene of candida albicans and application thereof |
| 01/04/2012 | CN101564533B Hepatitis E protein-nucleic acid composite vaccine and preparation method thereof |
| 01/04/2012 | CN101357942B Monoclonal antibody, Fab antibody and application for neutralizing enterohemorrhagic escherichia coli o157:H7 shiga toxin II |
| 01/04/2012 | CN101309699B Stabilized virus-like particles and epitope display systems |
| 01/04/2012 | CN101282744B Virus-like particles as vaccines for paramyxovirus |
| 01/04/2012 | CN101018863B Mutant pneumolysin proteins |
| 01/03/2012 | US8088974 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/03/2012 | US8088910 Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region |
| 01/03/2012 | US8088909 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 01/03/2012 | US8088898 Therapeutic use of anti-CS1 antibodies |
| 01/03/2012 | US8088894 Methods and compositions for Mycoplasma pneumoniae exotoxins |
| 01/03/2012 | US8088893 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088748 Antisense respiratory syncytial virus vaccine and therapy |
| 01/03/2012 | US8088737 Treating a cancer, in particular breast cancer, that overexpresses Her-2 by administering an ADAM inhibitor; novel variants of ADAM15 and ADAM15; synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds |
| 01/03/2012 | US8088618 Anti-IL 13 antibodies and uses thereof |
| 01/03/2012 | US8088569 Immunogens for treatment of neoplastic and infectious disease |
| 01/03/2012 | US8088408 Method and composition for delivery of medicants to animals |
| 01/03/2012 | US8088397 Human lymphocyte vaccine adjuvant |
| 01/03/2012 | US8088395 Phytol derived immunoadjuvants and their use in vaccine formulations |
| 01/03/2012 | US8088394 Expression vector comprising nucleotide sequences coding heat resistant bacterial toxin which exhibits reduced toxicity for use in vacccine development; bactericides |
| 01/03/2012 | US8088393 Swine influenza hemagglutinin variants |
| 01/03/2012 | US8088392 Capsid proteins and uses therefore |
| 01/03/2012 | US8088391 West nile virus vaccine |
| 01/03/2012 | US8088390 Methods for the early diagnosis of ovarian cancer |
| 01/03/2012 | US8088389 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088387 Potent, durable cytotoxic agents; tissue targeted therapy; tumors, autoimmune diseases, graft versus host disease, viral and parasite infections |
| 01/03/2012 | US8088386 Treatment of complement-associated disorders |
| 01/03/2012 | US8088385 PFKB3 inhibitor for the treatment of a proliferative cancer |
| 01/03/2012 | US8088384 Anti-NGF antibodies and methods using same |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088382 Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies |
| 01/03/2012 | US8088381 Methods of treatment of cardiovascular disease using anti-CTGF agents |
| 01/03/2012 | US8088380 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 01/03/2012 | US8088379 Modified T cell receptors and related materials and methods |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | US8088376 Fc variants with altered binding to FcRn |
| 01/03/2012 | US8088375 Anti-VEGF antibody |
| 01/03/2012 | US8088374 Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists |
| 01/03/2012 | US8088373 Autocrine growth factor receptor antibodies and methods |
| 01/03/2012 | US8088361 Treatment of allergic rhinitis in mammals with Clostridia neurotoxins |
| 01/03/2012 | US8088360 Treatment of infectious rhinitis in mammals with clostridia neurotoxins |
| 01/03/2012 | US8088357 Tumor-specific recognition molecules |
| 01/03/2012 | CA2632556C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/03/2012 | CA2547775C In ovo vaccination of campylobacter in avian species |
| 01/03/2012 | CA2539816C Antigens for an east coast fever vaccine |
| 01/03/2012 | CA2515392C Virosome-like-particles |
| 01/03/2012 | CA2501744C Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 01/03/2012 | CA2501087C Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 01/03/2012 | CA2457636C Antigen binding domains |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2425202C Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 01/03/2012 | CA2420949C Peptide selection method |
| 01/03/2012 | CA2419954C Use of il-6r/il-6 chimera in huntington's disease |
| 01/03/2012 | CA2404108C A method of preparing vaccines |
| 01/03/2012 | CA2399293C Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 01/03/2012 | CA2379539C Feline calicivirus genes and vaccines, in particular recombinant vaccines |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 01/03/2012 | CA2366433C Staphylococcus antigen and vaccine |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 01/03/2012 | CA2348658C Vaccine preparations containing attenuated toxin |
| 01/03/2012 | CA2334960C Combination of tgf-.beta. inhibition and immune stimulation to treat hyperproliferative diseases |
| 01/03/2012 | CA2304952C Mannose-receptor bearing cells and antigen conjugate for immunotherapy |
| 01/03/2012 | CA2288434C Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof |